Hot Features
Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.
hVIVO PLC 08 January 2024 hVIVO plc ("hVIVO" or the "Company") Appointment of Nominated Adviser and Joint Broker hVIVO plc (AIM & Euronext: HVO) , the world leader in...
hVIVO PLC 02 January 2024 hVIVO plc ("hVIVO" or the "Company") GBP6.3m HRV contract signed with biotechnology client Highlights -- Study to enter hVIVO's state-of-the-art...
hVIVO PLC 13 December 2023 The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulation...
hVIVO PLC 12 September 2023 hVIVO plc ("hVIVO" or the "Group") Interim results Stron g first half performance and record forward visibility Upgrade of Full Year Revenue and...
hVIVO PLC 01 September 2023 hVIVO plc ("hVIVO" or the "Company") Exercise of Warrants hVIVO plc (AIM & Euronext: HVO) has received notice of exercise of warrants by a...
hVIVO PLC 29 August 2023 hVIVO plc ("hVIVO" or the "Company") Plans for a new larger state-of-the-art facility to meet growing demand -- Capacity increase to 50 quarantine...
hVIVO PLC 24 August 2023 hVIVO plc ("hVIVO" or the "Company") Notice of results hVIVO plc (AIM & Euronext: HVO) , the world leader in testing infectious and respiratory...
hVIVO PLC 26 July 2023 hVIVO plc ("hVIVO" or the "Group") Trading Update Strong first half performance and record orderbook On track to deliver full year guidance and...
hVIVO PLC 25 July 2023 hVIVO plc ("hVIVO" or the "Company") GBP13.1m contract with global pharmaceutical client to develop an influenza B virus challenge model hVIVO plc (AIM...
hVIVO PLC 28 June 2023 hVIVO plc ("hVIVO" or the "Company") hVIVO to develop human metapneumovirus (hMPV) challenge model First client of the new hMPV model secured hVIVO plc...
| Zeitraum † | Änderung | Änderung % | Handelsbeginn | Hoch | Niedrig | Durchsch. Volumen | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -1.5 | -6.97674418605 | 21.5 | 21.83 | 19.5 | 129923 | 20.18472865 | DE |
| 4 | -3.5 | -14.8936170213 | 23.5 | 24.5 | 17.7 | 211036 | 20.87772507 | DE |
| 12 | -8.75 | -30.4347826087 | 28.75 | 30.5 | 17.7 | 142847 | 23.74039664 | DE |
| 26 | -6.5 | -24.5283018868 | 26.5 | 30.86 | 17.7 | 133926 | 26.00086051 | DE |
| 52 | -2 | -9.09090909091 | 22 | 80.5 | 17.7 | 166778 | 27.14222237 | DE |
| 156 | 5.5 | 37.9310344828 | 14.5 | 80.5 | 13.15 | 193741 | 21.75940358 | DE |
| 260 | 7.5 | 60 | 12.5 | 80.5 | 11.5 | 188400 | 21.73907835 | DE |
| Keine Diskussionen Gefunden. |
| Neuen Thread Erstellen |
Die zuletzt besuchten Aktien werden in diesem Feld angezeigt, so dass Sie leicht zu den Aktien zurückkehren können, die Sie zuvor angesehen haben.
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Premium
